Skip to main content

Table 2 Effective half-lives obtained from 6 and 24 h, \(T_{{{\text{eff}}}}^{6,24}\), and from 24 h, 48 h and 168 h, \(T_{{{\text{eff}}}}^{24,48,168}\), for the patients included in the study. The median (minimum, Q1, Q3, maximum) values are also shown

From: Individualisation of radiation protection recommendations for patients treated with [177Lu]Lu-DOTA-TATE

Patient

\(T_{{{\text{eff}}}}^{6,24}\) (h)

\(T_{{{\text{eff}}}}^{24,48,168}\) (h)

1

23 ± 6

68 ± 6

2

51 ± 29

70 ± 7

3

21 ± 5

58 ± 4

4

23 ± 6

67 ± 6

5

24 ± 7

58 ± 4

6

32 ± 11

65 ± 6

7

92 ± 95

92 ± 11

8

26 ± 8

53 ± 4

9

20 ± 5

47 ± 3

10

53 ± 32

119 ± 19

11

21 ± 5

44 ± 3

12

32 ± 11

45 ± 3

13

31 ± 11

42 ± 2

14

35 ± 14

54 ± 4

15

12 ± 2

50 ± 3

16

12 ± 2

38 ± 2

17

13 ± 2

35 ± 2

18

22 ± 6

64 ± 5

19

84 ± 79

97 ± 12

20

40 ± 18

57 ± 4

 

25 (12, 21, 36, 92)

58 (35, 47, 67, 119)